Skip to main content

UCLA State-of-the-Art Urology

$795.00

Quick Facts

Overview

Continuing Medical Education: Advances in Urology

Captured during the 46th annual conference, the UCLA State-of-the-Art Urology online CME course explores the most challenging management problems facing today’s practicing urologist. Distinguished faculty present the latest information, current therapies and expert techniques through 31 insightful lectures and nine panel discussions. Key topic areas include:

  • Male and Female Voiding Dysfunction, Reconstruction, Urethral Stricture Disease
  • Urolithiasis/Endourology
  • Men’s Health – Penile Rehab, Priapism, Anorgasmia
  • Prostate Cancer
  • Bladder Cancer
  • Testis Cancer
  • Kidney Cancer

Topics / Speakers

Male and Female Voiding Dysfunction, Reconstruction, Urethral Stricture Disease

Evaluation and Treatment of Mixed Urinary Incontinence in Women 2021
Victor W. Nitti, MD


Tips on 3rd Line Therapies for Overactive Bladder – Videos Included
Kathleen C. Kobashi, MD, FACS


Evaluation and Management of Recurrent UTIs in Women
Kathleen C. Kobashi, MD, FACS


Value of Genetic Testing and Next Generation Sequencing in Diagnosis of UTI
A. Lenore Ackerman, MD, PhD


Panel Discussion: Voiding Dysfunction and UTIs in Women
Audience Questions – Case Presentations
Moderator: Dr. Ja-Hong Kim
Panel: Drs. Ackerman, Baxter, Kobashi, and Nitti


Management of Urethral Stricture Disease in 2021: Dilation, Incision, Reconstruction
Kurt A. McCammon, MD


Underactive Bladder and Bladder Outlet Obstruction in Men: Is Surgery Indicated?
Victor W. Nitti, MD


Are Male Slings a Good Option for Mild and Moderate Stress Incontinence in Men?
Kurt A. McCammon, MD


Panel Discussion: Male Voiding Dysfunction
Audience Questions – Case Presentations
Moderator: Dr. Victor W. Nitti
Panel: Drs. Baxter, Kim, Kobashi, and McCammon

Urolithiasis/Endourology

Metabolic Evaluation and Medical Management of Urolithiasis: A Simplified Approach (Stone Tree)
Ralph V. Clayman, MD


Antibiotic Use: Managing Pre and Post-Op Infections in Patients Undergoing Endoscopic Surgery
Matthew Dunn, MD


Death of the PCNL – Increasing Utilization of Ureteroscopy Now and in the Future
Ralph V. Clayman, MD


Ureteral Stents – A Love/Hate Relationship
Kymora Scotland, MD, PhD


Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Matthew Dunn
Panel: Drs. Clayman and Scotland

Men’s Health – Penile Rehab, Priapism, Anorgasmia

Rehab of the Penis Post-Prostatectomy – The Hopkins Experience
Arthur L. Burnett, MD, MBA


How and Why to Set Up a Men’s Health Clinic
Jesse N. Mills, MD


Medical and Surgical Approaches to Priapism
Arthur L. Burnett, MD, MBA


Anorgasmia: What, Why, and How to Treat
Sriram Eleswarapu, MD, PhD


Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Jacob Rajfer
Panel: Drs. Burnett, Eleswarapu, and Mills

Video Sessions

Single Port Robotic Surgery – Does This Advance Our Field?
Arnold I. Chin, MD, PhD


Robotic Radical Prostatectomy – Techniques for Optimizing Continence, Potency, and Negative Margins
Robert E. Reiter, MD, MBA

Prostate Cancer

10 Debunked Myths About Prostate Cancer
Scott Eggener, MD


Improving the Quality of Decision Making in Prostate Cancer Using Shared Decision Making
Christopher S. Saigal, MD, MPH


Personalizing Adjuvant vs. Early Salvage Radiotherapy
Daniel E. Spratt, MD


Focal Therapy for Prostate Cancer – State of the Art
Scott Eggener, MD


Active Surveillance in 2021: Update on Intensity of Follow Up and Inclusion of 3+4 Disease
Leonard S. Marks, MD


Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Mark S. Litwin
Panel: Drs. Eggener, Marks, Reiter, Saigal, and Spratt


Personalizing Hormone Therapy with Radiation Therapy Role for Biomarkers
Daniel E. Spratt, MD


Management of Oligometastatic Disease in the World of PSMA Imaging
Robert E. Reiter, MD, MBA


Update on Therapy for Advanced Prostate Cancer Integrating Genetic Testing
Matthew Rettig, MD


Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Mark S. Litwin
Panel: Drs. Eggener, Marks, Rettig, Reiter, and Spratt

Bladder Cancer

New Advances in Bladder Cancer in 2021
Karim Chamie, MD, MSHS


Updates for Non-Muscle Invasive Bladder Cancer During BCG Shortage
Sam S. Chang, MD, MBA


Advances in Upper Tract Urothelial Cancer
Sam S. Chang, MD, MBA


Panel Discussion and Case Presentations
Moderator: Dr. Mark S. Litwin Panel: Drs. Chamie, Chang, Chin, Drakaki, and Kishan

Testis Cancer

Everything a Urologist Needs to Know About Testis Cancer
Scott Eggener, MD


Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Stanley K. Frencher, Jr.
Panel: Drs. Eggener, Drakaki, and Litwin

Kidney Cancer

Role for Elective Radical Nephrectomy for T1B/T2A Renal Tumors
Brian Shuch, MD


Management Considerations for Bilateral/Multifocal Renal Tumors
Brian Shuch, MD


Panel Discussion and Case Presentations
Moderator: Dr. Brian Shuch
Panel: Drs. Chamie, Liu, Padia, Pantuck and Ye

Faculty

Course Chair

William J. Aronson, MD

Course Co-Chairs

Craig Canfield, MD

Karim Chamie, MD, MSHS

Guest Faculty

Arthur L. Burnett, MD, MBA

Patrick C. Walsh Distinguished Professor of Urology, Oncology

The Brady Urological Institute

Department of Urology

Johns Hopkins Medical Institutions

Baltimore, MD

Sam S. Chang, MD, MBA

Patricia and Rodes Hart Professor of Urologic Surgery

Vanderbilt University Medical Center

Chief Surgical Officer

Vanderbilt Ingram Cancer Center

Nashville, TN

Ralph V. Clayman, MD

Distinguished Professor/Endowed Chair in Endourology

Dean – emeritus

University of California, Irvine

Department of Urology

Orange, CA

Scott Eggener, MD

Professor of Surgery

University of Chicago

Chicago, IL

Kathleen C. Kobashi, MD, FACS

Head, Section of Urology and Renal Transplantation

Virginia Mason Medical Center

Seattle, WA

Kurt A. McCammon, MD

Devine Chair in Genitourinary Reconstructive Surgery

Chairman and Program Director

Professor Department of Urology

Eastern Virginia Medical School

Norfolk, VA

Daniel E. Spratt, MD

Professor of Radiation Oncology

Laurie Snow Endowed Research Professor

Associate Chair, Clinical Research

Chair, Genitourinary Clinical Research, Rogel Cancer Center

University of Michigan

Ann Arbor, MI

David Geffen School of Medicine at UCLA
Department of Urology Faculty

Mark S. Litwin, MD, MPH

Professor and Chair

Department of Urology

Professor of Health Policy and Management

School of Public Health

Sam S. Chang, MD, MBA
A. Lenore Ackerman, MD, PhD
Z. Chad Baxter, MD
Arnold I. Chin, MD, PhD
Matthew Dunn, MD

Sriram Eleswarapu, MD, PhD
Stanley Frencher, Jr., MD, MPH
Ja-Hong Kim, MD
Leonard S. Marks, MD
Jesse N. Mills, MD
Victor W. Nitti, MD
Allan J. Pantuck, MD, MS
Jacob Rajfer, MD
Robert E. Reiter, MD, MBA
Christopher S. Saigal, MD, MPH
Kymora Scotland, MD
Brian Shuch, MD

David Geffen School of Medicine at UCLA
UCLA Faculty

Alexandra Drakaki, MD, PhD

Assistant Professor of Medicine and Urology

Director - Genitourinary Medical Oncology Program

Co-Director of Research, GU Trials Program

Division of Hematology/Oncology and Institute of Urologic Oncology

Amar U. Kishan, MD

Assistant Professor

Chief of Genitourinary Oncology Service

Vice Chair of Clinical and Translational Research

Department of Radiation Oncology

Sandy T. Liu, MD

Division of Hematology-Oncology

Department of Medicine

Institute of Urologic Oncology

Department of Urology

Siddharth A. Padia, MD

Professor

Interventional Radiology

Director, IR at UCLA Santa Monica

Matthew Rettig, MD

Professor of Medicine and Urology

Medical Director, Prostate Cancer Program

Institute of Urologic Oncology

Associate Director, Hematology-Oncology Fellowship Program

David Geffen School of Medicine at UCLA

Chief, Division of Hematology-Oncology

VA Greater Los Angeles – West Los Angeles

Huihui Ye, MD

Chief of Genitourinary Pathology

Associate Professor, Department of Pathology

Accreditation

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this enduring activity for a maximum of 16 AMA PRA Category 1 Credits™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Date of Original Release: April 16, 2021
Date Credits Expire: April 15, 2024
Estimated Time to Complete: 16 hours

 

CME credit is awarded upon successful completion of a course evaluation and post-test.

Learning Objectives

At the completion of this program, participants should be better able to:

  • Manage prostate cancer patients with active surveillance
  • Utilize molecular markers for personalizing prostate cancer care
  • Counsel patients on focal therapy for prostate cancer
  • Utilize PSMA imaging for managing patients with oligometastatic prostate cancer
  • Manage bladder cancer patients in the era of BCG shortages
  • Manage patients with upper tract urothelial cancer
  • Manage bilateral and multifocal renal tumors
  • Treat patients with testis cancer
  • Manage male and female voiding dysfunction
  • Utilize male slings for post-prostatectomy incontinence
  • Manage patients with kidney and ureteral stones
  • Treat patients with priapism
  • Utilize strategies for post-prostatectomy penile rehabilitation
  • Understand and treat anorgasmia
  • Understand the therapies for advanced prostate cancer and role for genetic testing
  • Manage recurrent UTIs in women and utilize genetic testing for UTI diagnosis
  • Manage urethral stricture disease
  • Carry out a metabolic evaluation for urolithiasis
  • Improve shared decision making in patients with prostate cancer

Intended Audience

This course explores the most challenging management problems facing the practicing urologist.

Quick Facts

a CMEinfo video production

Provider: David Geffen School of Medicine at UCLA

Course Chair:
William J. Aronson, MD

Course Co-Chairs:
Craig Canfield, MD
Karim Chamie, MD, MSHS

Credits: Earn a maximum of 16.00 AMA PRA Category 1 Credits

Overview

Specialties

Topics / Speakers

Faculty

Accreditation

Further Information

Further Information

Further Information

Reviews

SKU: URV455E0